BackImpel Pharmaceuticals Overview

Impel Pharmaceuticals Short-Term Investments

Latest short-term investments for IMPL: $0.

Get informed when a big investor buys or sells

+ Follow
Short-Term Investments
$0.00
↓ 100.00% YoYΔ $-4.79M vs prior year quarter

Peer trimmed avg / median

Loading

Impel Pharmaceuticals Short-Term Investments History

Loading

Impel Pharmaceuticals vs. peers: Short-Term Investments Comparison

Loading

Impel Pharmaceuticals Short-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Impel Pharmaceuticals (IMPL) FAQ

As of the most recent data (September 2023), IMPL shows a short-term investments of $0. That compares with $4.8M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMPL's short-term investments is now $0 (was $4.8M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Impel Pharmaceuticals is outperforming or lagging.

Tracking IMPL's short-term investments over time shows whether Impel Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $4.8M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this short-term investments page, Stockcircle has Impel Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect short-term investments (currently $0) with ownership activity and broader fundamentals.

Impel Pharmaceuticals's short-term investments is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.